Tag: Aatru

 As part of Aatru Medical, LLC (“Aatru”) commercial planning, the company is pleased to announce a Latin America distribution agreement with Salus Biomedical, for the NPSIMS product. The product received recent FDA 510(k) clearance, and Aatru is in the process of finalizing market introduction plans. Initial markets include Latin America, with U.S. and additional global markets to follow. “We are very excited about this next phase of Aatru development, as we bring the product to market, providing access for clinicians and patients to this truly innovative product,” stated Edward Armstrong, President, Aatru Medical. The patented NPSIMS utilizes a safe and ... Read more

 Aatru Medical, LLC (“Aatru”) today announced U.S. Food and Drug Administration (FDA) 510(k) Class II clearance of the NPSIMS™ Negative Pressure Surgical Incision Management System. The NPSIMS utilizes an innovative mode-of-action that eliminates the expensive electro-mechanical pump, battery, and electronics found in most other negative pressure wound therapy (NPWT) systems being deployed for closed surgical incision applications. The single-use, disposable NPSIMS is easily activated and operates silently during therapy delivery. A patented preassembled dressing provides ease-of-application with exceptional “sealing” capability while providing patient comfort and ergonometric appeal. The FDA effort was led by Aatru President and Board member Edward Armstrong ... Read more